Novel Carboline-Based Ferroptosis Inhibitor Ameliorates Acute Liver Injury by Remodeling Phosphatidylcholine.

Key Points

• The aim is to evaluate the effectiveness of a carboline-based ferroptosis inhibitor in treating acute liver injury.
• Assessment of liver injury models including ischemia-reperfusion, ConA, and APAP-induced injuries.
• Evaluation of the efficacy of the novel ferroptosis inhibitor in preventing tissue damage.
• The ferroptosis inhibitor significantly reduces acute liver injury compared to controls.
• Protection observed against ischemia-reperfusion injury and APAP-induced damage, indicating strong therapeutic potential.